Experimental Brain Metastasis

  • Kenneth W. Brunson
  • Garth L. Nicolson
Part of the Metastasis: A Monograph Series book series (METS, volume 2)

Abstract

Tumor metastasis is a complex, multistep process that appears to be dependent upon a number of host and tumor properties (Fidler 1975a; Weiss 1977a; Fidler and Nicolson 1979; Nicolson 1978a). First, emergent malignant tumor cells must be able to survive and grow in a potentially hostile environment and proliferate to form a primary tumor. Once a primary tumor is established, invasion of surrounding normal tissues may take place by mechanical infiltration (Eaves 1973), enzymatic digestion (Dresden et al. 1972), or both. If a primary tumor is able to penetrate blood vessels, malignant cells can be transported to distant sites. Several factors probably influence tumor-cell detachment (Weiss 1977b) and survival in the circulation. While in the blood, tumor cells (or cell emboli) can interact with a variety of humoral or cellular components (such as lymphocytes, platelets, endothelial cells). The hostile environment of the circulatory system probably causes the death of most blood-borne malignant cells originating from solid tumors; only a small percentage of tumor cells actually survive to form secondary tumors (Fidler 1970, 1976). Survival at a distant site appears to involve successful implantation in the microcirculation, extravasation and establishment of a proper environment for subsequent vascularization and growth.

Keywords

Melanoma Cell Retinoic Acid Brain Metastasis Melanoma Line Variant Cell Line 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beresford, H. R. Melanoma of the nervous system. Neurology 19: 59–65, 1969.PubMedGoogle Scholar
  2. Brunson, K. W.; Beattie, G.; and Nicolson, G. L. In vivo selection of malignant melanoma for organ preference of experimental metastasis. J. Cell Biol 75:209a, 1977.Google Scholar
  3. Brunson, K. W.; Beattie, G.; and Nicolson, G. L. Selection and altered properties of brain-colonising metastatic melanoma. Nature 272: 543–545, 1978.PubMedCrossRefGoogle Scholar
  4. Brunson, K. W., and Nicolson, G. L. Selection of malignant melanoma variant cell line for ovary colonization. J. Supramol Struct., 1980.Google Scholar
  5. Dresden, M. H.; Heilman, S. A.; and Schmidt, J. D. Collagenolytic enzymes in human neoplasms. Cancer Res. 32: 993–996, 1972.PubMedGoogle Scholar
  6. Dunn, T. B.; Normal and pathologic anatomy of the reticular tissue in laboratory mice, with a classification and discussion of neoplasms. J. Natl Cancer Inst 14: 1281–1433, 1954.PubMedGoogle Scholar
  7. Eaves, G. The invasive growth of malignant tumors as a purely mechanical process. J. Pathol 109: 233–237, 1973.PubMedCrossRefGoogle Scholar
  8. Fidler, I. J. Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125I-5-iodo-2’-deoxyuridine. J. Natl Cancer Inst. 45: 775–782, 1970.Google Scholar
  9. Fidler, I. J. Selection of successive tumor lines for metastasis. Nature [New Biol] 242: 148–149, 1973.Google Scholar
  10. Fidler, I. J. Mechanisms of cancer invasion and metastasis. In Cancer: a comprehensive treatise. Biology of Tumors: Surfaces, Immunology, and Comparative Pathology, ed. F. F. Becker, Vol. 4. New York: Plenum Press, 1975a.Google Scholar
  11. Fidler, I. J. Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 35: 218–224, 1975b.PubMedGoogle Scholar
  12. Fidler, I. J. Patterns of tumor cell arrest and development. In Fundamental aspects of metastasis, ed. L. Weiss. Amsterdam: North-Holland Publishing Co., 1976.Google Scholar
  13. Fidler, I.J. Tumor heterogeneity and the biology of cancer and metastasis. Cancer Res. 38: 2651–2660, 1978.PubMedGoogle Scholar
  14. Fidler, I. J., and Nicolson, G. L. Organ selectivity for implantation, survival and growth of B16 melanoma variant tumor lines. J. Natl Cancer Inst. 57: 1199–1202, 1976.PubMedGoogle Scholar
  15. Fidler, I. J., and Nicolson, G. L. Fate of recirculating B16 melanoma metastatic variant cells in parabiotic syngeneic recipients. J. Natl Cancer Inst. 58: 1867–1872, 1977.PubMedGoogle Scholar
  16. Fidler, I. J., and Nicolson, G. L. The immunobiology of experimental metastatic melanoma. Cancer Biol Rev., 1980.Google Scholar
  17. Kinsey, D. L. An experimental study of preferential metastasis. Cancer 13: 674–676, 1960.PubMedCrossRefGoogle Scholar
  18. Lotan, R. et al. Characterization of the inhibitory effects of retinoids on the in vitro growth of two malignant murine melanomas. J. Natl Cancer Inst. 60: 1035–1041, 1978.PubMedGoogle Scholar
  19. Lotan, R., and Nicolson, G. L. Inhibitory effects of retinoic acid or retinyl acetate on the growth of untransformed, transformed and tumor cells in vitro. J. Natl Cancer Inst. 59: 1717–1722, 1977.PubMedGoogle Scholar
  20. Lotan, R., and Nicolson, G. L. Heterogeneity in growth inhibition by retinoic acid or metastatic B16 melanoma clones and in vivo selected cell variant lines. Cancer Res. 39: 4767–4771, 1980.Google Scholar
  21. Marchalonis, J. J.; Cone, R. E.; and Santer, V. Enzymatic iodination: a probe for accessible surface proteins of normal and neoplastic lymphocytes. Biochem. J. 124: 912–927, 1971.Google Scholar
  22. Nicolson, G. L. Experimental tumor metastasis: characteristics and organ specificity. Bioscience 28: 441–447, 1978a.CrossRefGoogle Scholar
  23. Nicolson, G. L. Cell surface proteins and glycoproteins of metastatic murine melanomas and sarcomas. In Biological markers in neoplasia: basic and applied aspects, ed. R. W. Ruddon. New York: North-Holland Publishing Co., 1978b.Google Scholar
  24. Nicolson, G. L. et al: Cell interactions in the metastatic process: some cell surface properties associated with successful blood-borne tumor spread. In Cell and tissue interactions, ed. J. Lash and M. M. Burger. New York: Raven Press, 1977.Google Scholar
  25. Nicolson, G. L., and Brunson, K. W. Organ specificity of malignant B16 melanomas: in vivo selection for organ preference of blood-borne metastasis. Gann. Monogr. Cancer Res. 20: 15–24, 1977.Google Scholar
  26. Nicolson, G. L.; Brunson, K. W.; and Fidler, I. J. Specificity of arrest, survival and growth of selected metastatic variant cell lines. Cancer Res., 38: 4105–4111, 1978.PubMedGoogle Scholar
  27. Parks, R. C. Organ-specific metastasis of a transplantable reticulum cell sarcoma. J. Natl Cancer Inst. 52: 971–973, 1974.PubMedGoogle Scholar
  28. Pilgrim, H. I. The kinetics of the organ-specific metastasis of a transplantable reticuloendothelial tumor. Cancer Res. 29: 1200–1205, 1969.PubMedGoogle Scholar
  29. Posner, J. B. Management of central nervous system metastases. Semin. Oncol 4: 81–91, 1977.PubMedGoogle Scholar
  30. Posner, J. B., and Shapiro, W. R. Brain tumor. Current status of treatment and its complications. Arch. Neurol 32: 781–784, 1975.PubMedGoogle Scholar
  31. Potter, M.; Fahey, J. L.; and Pilgrim, H. I. Abnormal serum protein and bone destruction in transmissible mouse plasma cell endoplasm. Proc. Soc. Exp. Biol Med. 94: 327–333, 1957.PubMedGoogle Scholar
  32. Robbins, J. C. et al. Cell-surface changes in a Ricinus communis toxin- resistant variant of a murine lymphoma. J. Natl Cancer Inst. 58: 1027–1033, 1977.PubMedGoogle Scholar
  33. Smith, R. T., and Landy, M. Immune Surveillance. New York: Academic Press, 1971.Google Scholar
  34. Sporn, M. B. Retinoids and carcinogenesis. Nutr. Rev. 35: 65–69, 1977.PubMedCrossRefGoogle Scholar
  35. Sugarbaker, E. D. The organ selectivity of experimentally induced metastasis in rats. Cancer 5: 606–612, 1952.PubMedCrossRefGoogle Scholar
  36. Weiss, L. A pathobiologic overview of metastasis. Semin. Oncol. 4: 5–19, 1977a.PubMedGoogle Scholar
  37. Weiss, L. Cell detachment and metastasis. Gann. Monogr. Cancer Res. 20: 25–35, 1977b.Google Scholar
  38. Zeidman, I. Metastasis: a review of recent advances. Cancer Res. 17: 157–162, 1957.PubMedGoogle Scholar
  39. Zeidman, I. The fate of circulating tumor cells. I. Passage of cells through capillaries. Cancer Res. 21: 38–39, 1961.PubMedGoogle Scholar
  40. Zeidman, I., and Buss, J. M. Transpulmonary passage of tumor cell emboli. Cancer Res. 12: 731–733, 1952.PubMedGoogle Scholar

Copyright information

© G.K. Hall & Co. 1980

Authors and Affiliations

  • Kenneth W. Brunson
  • Garth L. Nicolson

There are no affiliations available

Personalised recommendations